Wednesday, July 8, 2026

pharma · MASH · MASLD · SGMT

Sagimet Biosciences

Sagimet Biosciences patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

155 Bovet Rd, Suite 303, San Mateo, California 94402, US HQ
27 Employees
Public company Type
SGMT · NYSE Ticker
Company details
Status
Public
HQ
155 Bovet Rd, Suite 303, San Mateo, California 94402, US
Employees
27
Programs
12
Drugs
4
Patents
1
Intelligence · Patents

Sagimet Biosciences patents

1 pharmaceutical patents indexed for Sagimet Biosciences. 0 expire within 24 months.

Sagimet Biosciences has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 11622968

    Heterocyclic modulators of lipid synthesis

    Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Sagimet Biosciences have?

1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Sagimet Biosciences patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.